PhaseBio Pharmaceuticals, Inc.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PhaseBio Pharmaceuticals, Inc. COM, CUSIP 717224100.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PhaseBio Pharmaceuticals, Inc. COM, CUSIP 717224100.